학술논문

Mechanical circulatory support in acute myocardial infarction and cardiogenic shock: Challenges and importance of randomized control trials
Document Type
article
Source
Catheterization and Cardiovascular Interventions. 98(7)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Clinical Trials and Supportive Activities
Cardiovascular
Clinical Research
Heart Disease
Heart Disease - Coronary Heart Disease
Heart-Assist Devices
Humans
Intra-Aortic Balloon Pumping
Myocardial Infarction
Randomized Controlled Trials as Topic
Shock
Cardiogenic
Treatment Outcome
United States
acute myocardial infarction
STEMI
cardiogenic shock
clinical trials
ECMO
IABP
Tandem
Impella
mechanical circulatory support
ECMO/IABP/Tandem/Impella
acute myocardial infarction/STEMI
Cardiorespiratory Medicine and Haematology
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Language
Abstract
BackgroundAcute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is associated with significant morbidity and mortality.MethodsWe provide an overview of previously conducted studies on the use of mechanical circulatory support (MCS) devices in the treatment of AMI-CS and difficulties which may be encountered in conducting such trials in the United States.ResultsWell powered randomized control trials are difficult to conduct in a critically ill patient population due to physician preferences, perceived lack of equipoise and challenges obtaining informed consent.ConclusionsWith growth in utilization of MCS devices in patients with AMI-CS, efforts to perform well-powered, randomized control trials must be undertaken.